Fucus vesiculosus / Phyllitis scolopendrium comp. Gocce per uso orale

Country: সুইজারল্যান্ড

ভাষা: ইতালীয়

সূত্র: Swissmedic (Swiss Agency for Therapeutic Products)

সক্রিয় উপাদান:

adonis vernalis (HAB) D3, alchemilla vulgaris (HAB) D2, arnica montana (HAB) D3, carbo vegetabilis (HAB) D6, fucus vesiculosus (HAB) D2, hyssopus officinalis e herba rec. D2 (HAB 3a), nasturtium officinale (HAB) D2, phyllitis scolopendrium e herba rec. D2 (HAB 3a), phytolacca americana (HAB) D4

থেকে পাওয়া:

Regena AG

INN (International Name):

adonis vernalis (HAB) D3, alchemilla vulgaris (HAB) D2, arnica montana (HAB) D3, carbo vegetabilis (HAB) D6, fucus vesiculosus (HAB) D2, hyssopus officinalis e herba rec. D2 (HAB 3a), nasturtium officinale (HAB) D2, phyllitis scolopendrium e herba rec. D2 (HAB 3a), phytolacca americana (HAB) D4

ফার্মাসিউটিকাল ফর্ম:

Gocce per uso orale

রচনা:

adonis vernalis (HAB) D3 0.11 ml, alchemilla vulgaris (HAB) D2 0.11 ml, arnica montana (HAB) D3 0.11 ml, carbo vegetabilis (HAB) D6 0.11 ml, fucus vesiculosus (HAB) D2 0.11 ml, hyssopus officinalis e herba rec. D2 (HAB 3a) 0.11 ml, nasturtium officinale (HAB) D2 0.11 ml, phyllitis scolopendrium e herba rec. D2 (HAB 3a) 0.11 ml, phytolacca americana (HAB) D4 0.11 ml, aqua purificata, ethanolum 96 per centum 0.39 g, ad solutionem pro 1 ml, corresp. 47 guttae, corresp. ethanolum 49 % V/V.

শ্রেণী:

D

Therapeutic group:

Farmaci Omeopatici

Therapeutic area:

Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)

অনুমোদন অবস্থা:

zugelassen

অনুমোদন তারিখ:

2011-03-31